These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 22417220)

  • 21. 3-amino-1,2,4-benzotriazine 4-oxide: characterization of a new metabolite arising from bioreductive processing of the antitumor agent 3-amino-1,2,4-benzotriazine 1,4-dioxide (tirapazamine).
    Fuchs T; Chowdhury G; Barnes CL; Gates KS
    J Org Chem; 2001 Jan; 66(1):107-14. PubMed ID: 11429885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of functional groups on reduction and activation of quinone bioreductive agents by DT-diaphorase.
    Fourie J; Oleschuk CJ; Guziec F; Guziec L; Fiterman DJ; Monterrosa C; Begleiter A
    Cancer Chemother Pharmacol; 2002 Feb; 49(2):101-10. PubMed ID: 11862423
    [TBL] [Abstract][Full Text] [Related]  

  • 23. (13)C-labeled indolequinone-DTPA-Gd conjugate for NMR probing cytochrome:P450 reductase-mediated one-electron reduction.
    Komatsu H; Tanabe K; Nishimoto S
    Bioorg Med Chem Lett; 2011 Jan; 21(2):790-3. PubMed ID: 21168332
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reductive metabolism of the nitroimidazole-based hypoxia-selective cytotoxin NLCQ-1 (NSC 709257).
    Papadopoulou MV; Ji M; Rao MK; Bloomer WD
    Oncol Res; 2003; 14(1):21-9. PubMed ID: 14552588
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An activatable azophenyl fluorescent probe for hypoxic fluorescence imaging in living cells.
    Liu Z; Zhang Z; Li J; Zhu G; Li Q
    Luminescence; 2024 Jun; 39(6):e4798. PubMed ID: 38825785
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioreduction of idarubicin and formation of ROS responsible for DNA cleavage by NADPH-cytochrome P450 reductase and its potential role in the antitumor effect.
    Celik H; Arinç E
    J Pharm Pharm Sci; 2008; 11(4):68-82. PubMed ID: 19183515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fragmentation of the quinoxaline N-oxide bond to the ˙OH radical upon one-electron bioreduction.
    Yadav P; Marshall AJ; Reynisson J; Denny WA; Hay MP; Anderson RF
    Chem Commun (Camb); 2014 Nov; 50(89):13729-31. PubMed ID: 25248989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bioreductive metabolism of the novel fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitroimidazolyl) acetamide (SR-4554).
    Aboagye EO; Lewis AD; Tracy M; Workman P
    Biochem Pharmacol; 1997 Dec; 54(11):1217-24. PubMed ID: 9416972
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Direct measurement of pO2 distribution and bioreductive enzymes in human malignant brain tumors.
    Rampling R; Cruickshank G; Lewis AD; Fitzsimmons SA; Workman P
    Int J Radiat Oncol Biol Phys; 1994 Jun; 29(3):427-31. PubMed ID: 8005794
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Nitroaryl compounds as potential fluorescent probes for hypoxia. II. Identification and properties of reductive metabolites.
    Stratford MR; Clarke ED; Hodgkiss RJ; Middleton RW; Wardman P
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1353-6. PubMed ID: 6547940
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enzyme-activated, hypoxia-selective DNA damage by 3-amino-2-quinoxalinecarbonitrile 1,4-di-N-oxide.
    Chowdhury G; Kotandeniya D; Daniels JS; Barnes CL; Gates KS
    Chem Res Toxicol; 2004 Nov; 17(11):1399-405. PubMed ID: 15540937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diflavin oxidoreductases activate the bioreductive prodrug PR-104A under hypoxia.
    Guise CP; Abbattista MR; Tipparaju SR; Lambie NK; Su J; Li D; Wilson WR; Dachs GU; Patterson AV
    Mol Pharmacol; 2012 Jan; 81(1):31-40. PubMed ID: 21984255
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of human reductases that activate the dinitrobenzamide mustard prodrug PR-104A: a role for NADPH:cytochrome P450 oxidoreductase under hypoxia.
    Guise CP; Wang AT; Theil A; Bridewell DJ; Wilson WR; Patterson AV
    Biochem Pharmacol; 2007 Sep; 74(6):810-20. PubMed ID: 17645874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Emission under hypoxia: one-electron reduction and fluorescence characteristics of an indolequinone-coumarin conjugate.
    Tanabe K; Hirata N; Harada H; Hiraoka M; Nishimoto S
    Chembiochem; 2008 Feb; 9(3):426-32. PubMed ID: 18224643
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Monitoring of biological one-electron reduction by (19)F NMR using hypoxia selective activation of an (19)F-labeled indolequinone derivative.
    Tanabe K; Harada H; Narazaki M; Tanaka K; Inafuku K; Komatsu H; Ito T; Yamada H; Chujo Y; Matsuda T; Hiraoka M; Nishimoto S
    J Am Chem Soc; 2009 Nov; 131(44):15982-3. PubMed ID: 19842623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Radical Chemistry and Cytotoxicity of Bioreductive 3-Substituted Quinoxaline Di-N-Oxides.
    Anderson RF; Yadav P; Shinde SS; Hong CR; Pullen SM; Reynisson J; Wilson WR; Hay MP
    Chem Res Toxicol; 2016 Aug; 29(8):1310-24. PubMed ID: 27380897
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cytochrome P450 2S1 is reduced by NADPH-cytochrome P450 reductase.
    Xiao Y; Shinkyo R; Guengerich FP
    Drug Metab Dispos; 2011 Jun; 39(6):944-6. PubMed ID: 21430234
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 1,2-Bis(methylsulfonyl)-1-(2-chloroethyl)-2-[[1-(4-nitrophenyl)ethoxy]carbonyl]hydrazine: an anticancer agent targeting hypoxic cells.
    Seow HA; Penketh PG; Shyam K; Rockwell S; Sartorelli AC
    Proc Natl Acad Sci U S A; 2005 Jun; 102(26):9282-7. PubMed ID: 15964988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The reductive activation of the antitumor drug RH1 to its semiquinone free radical by NADPH cytochrome P450 reductase and by HCT116 human colon cancer cells.
    Hasinoff BB; Begleiter A
    Free Radic Res; 2006 Sep; 40(9):974-8. PubMed ID: 17015278
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A fluorescent probe based on tetrahydro[5]helicene for highly selective recognition of hydrogen sulfide.
    Lei Y; Wang KP; Chen S; Zhang Q; Hu ZQ
    Spectrochim Acta A Mol Biomol Spectrosc; 2018 Nov; 204():295-300. PubMed ID: 29945112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.